Showing results (271-280 of 331) with videos related to

Sort By:
Pageof 34
Oncotarget|October 30, 2016
Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinomaWooil Kim, Ho Yun Lee, Sin-Ho Jung, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 5, 2021
Long-term outcomes of aortic root operations in the United States among Medicare beneficiariesBabatunde A Yerokun, Prashanth Vallabhajosyula, Andrew M Vekstein, et al.
Molecular Cancer Therapeutics|June 24, 2010
Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapyChristina K Augustine, Hiroaki Toshimitsu, Sin-Ho Jung, et al.
The Lancet. Haematology|May 30, 2020
Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trialGita Thanarajasingam, John P Leonard, Thomas E Witzig, et al.
Annals of Surgery|November 3, 2016
Perioperative Fresh Red Blood Cell Transfusion May Negatively Affect Recipient Survival After Liver TransplantationSangbin Han, Ji Hye Kwon, Sun Hee Jung, et al.
Plos One|May 27, 2016
A Risk Prediction Model Based on Lymph-Node Metastasis in Poorly Differentiated-Type Intramucosal Gastric CancerJeung Hui Pyo, Hyuk Lee, Byung-Hoon Min, et al.
The Lancet. Haematology|March 19, 2017
Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trialsSonali M Smith, Brandelyn N Pitcher, Sin-Ho Jung, et al.
Korean Journal of Anesthesiology|December 8, 2016
Randomized trial of subfascial infusion of ropivacaine for early recovery in laparoscopic colorectal cancer surgerySang Hyun Lee, Woo-Seog Sim, Go Eun Kim, et al.
Annals of Surgical Oncology|November 18, 2020
Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in MelanomaNorma E Farrow, Eda K Holl, Jeanne Jung, et al.
Leukemia & Lymphoma|February 1, 2011
A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254Richard R Furman, Michael L Grossbard, Jeffrey L Johnson, et al.
Pageof 34